Effects of immunisation against PCSK9 in mice bearing melanoma
Introduction Inhibition of proprotein convertase subtilisin/kexin 9 (PCSK9) is an established modality for the treatment of hypercholesterolaemia. However, the impact of PCSK9 inhibition in other situations such as cancer remains largely unknown. The current study was conducted to study the effects...
Guardado en:
Autores principales: | Amir Abbas Momtazi-Borojeni, Maryam Ebrahimi Nik, Mahmoud Reza Jaafari, Maciej Banach, Amirhossein Sahebkar |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Termedia Publishing House
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6dd2f54a36384257a4141794031b4087 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Adherence to the paediatric immunisation schedule in England
por: Jorgen Bauwens, et al.
Publicado: (2021) -
PCSK9 Gene Polymorphisms Associated With the Risk of Myocardial Infarction in Iranian Patients
por: Farshad Namordizadeh, et al.
Publicado: (2021) -
Safety and Tolerability of PCSK9 Inhibitors: Current Insights
por: Kosmas CE, et al.
Publicado: (2020) -
Beneficial effects of PCSK9 inhibition with alirocumab in familial hypercholesterolemia involve modulation of new immune players
por: Patrice Marques, et al.
Publicado: (2022) -
Is PCSK9 Associated with Plasma Lipid Levels in a Sub-Saharan African Population of Patients with Obesity and Type 2 Diabetes?
por: Mba CM, et al.
Publicado: (2019)